Reginald M Gorczynski

This inventor holds 18 USPTO granted patents and 5 published patent applications. Top assignees: Trillium Therapeutics Inc., Network Immunology Inc., Transplantation Technologies Inc.. Active years: 2002-2024.

USPTO Granted Patents = 18 (Patent Applications = 5)

% Patents Active = 16.7

Average Co-Inventor Count = 1.6

ph-index = 9

Forward Citations = 239(Granted Patents)

Company Filing History:

16 out of 29

Trillium Therapeutics Inc.

patents

1 out of 1

Network Immunology Inc.

patent

1 out of 2

Transplantation Technologies Inc.

patents

Years Active: 2002-2024

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12090202 - Combination of plasma immunoglobulin and antigen-specific immunoglobulin for the modification of the immune system and the treatment or prevention of allergic diseases (2024-09-17),

2. 8206897 - Assay for soluble CD200 (2012-06-26),

3. 8187598 - Methods of treating cancer by administering antibodies to CD200 (2012-05-29),

4. 7902151 - Methods and compositions for modulating immunity (2011-03-08),

5. 7887798 - Methods of treating cancer by administering antibodies to CD200 (2011-02-15),

6. 7553811 - Methods and compositions for modulating immunity (2009-06-30),

7. 7452536 - Methods of treating cancer by administering antibodies to CD200 (2008-11-18),

8. 7368535 - CD200 receptors (2008-05-06),

9. 7291330 - MD-1 inhibitors as immune suppressants (2007-11-06),

10. 7238352 - Methods and compositions for modulating tumor growth (2007-07-03),

11. 7223729 - Methods of treating allergy by administering a CD200 protein (2007-05-29),

12. 7205386 - Truncated CD200 (2007-04-17),

13. 7196243 - Transgenic animal containing CD200 and uses therefor (2007-03-27),

14. 6984625 - Methods and compositions for modulating autoimmunity (2006-01-10),

15. 6955811 - Methods of inhibiting immune response suppression by administering antibodies to OX-2 (2005-10-18),

Title: Reginald M Gorczynski: Innovator in Immunology

Introduction

Reginald M Gorczynski is a prominent inventor based in Willowdale, CA, known for his significant contributions to the field of immunology. With a total of 18 patents to his name, Gorczynski has made remarkable advancements in the treatment and prevention of allergic diseases.

Latest Patents

Among his latest patents is a groundbreaking method that combines plasma immunoglobulin and antigen-specific immunoglobulin for modifying the immune system. This innovative approach aims to treat or prevent allergic diseases by utilizing intramuscular immunoglobulin in conjunction with polyclonal antigen-specific immunoglobulin. Additionally, he has developed an assay for soluble CD200, which involves methods for identifying subjects with elevated CD200 levels. This method includes assaying biological fluids to determine soluble CD200 levels, providing valuable diagnostic tools for medical conditions associated with CD200.

Career Highlights

Gorczynski has worked with notable companies such as Trillium Therapeutics Inc. and Transplantation Technologies Inc. His work has significantly impacted the field of immunology, leading to advancements in therapeutic methods and diagnostic techniques.

Collaborations

Throughout his career, Gorczynski has collaborated with esteemed colleagues, including David A Clark and Philip Marsden. These partnerships have fostered innovation and contributed to the development of new medical solutions.

Conclusion

Reginald M Gorczynski's contributions to immunology through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to influence the treatment of allergic diseases and the understanding of immune system modifications.